MEEDER ASSET MANAGEMENT INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,00017
+6.2%
0.00%
Q2 2022$0
-100.0%
16
-93.5%
0.00%
Q1 2022$8,0000.0%245
-16.1%
0.00%
Q3 2021$8,0000.0%292
+12.7%
0.00%
Q2 2021$8,000
-84.0%
259
-86.5%
0.00%
-100.0%
Q1 2021$50,000
-51.0%
1,919
-61.2%
0.00%
-57.1%
Q3 2020$102,000
+264.3%
4,946
+503.9%
0.01%
+250.0%
Q1 2019$28,000
-6.7%
819
-6.9%
0.00%
-33.3%
Q4 2018$30,000
+328.6%
880
+511.1%
0.00%
+200.0%
Q3 2018$7,000
-100.0%
144
-40.0%
0.00%0.0%
Q2 2018$14,364,000
+26016.4%
240
-79.9%
0.00%
-80.0%
Q1 2018$55,000
-45.0%
1,192
-52.7%
0.01%
-37.5%
Q4 2017$100,000
+9.9%
2,521
+11.0%
0.01%
-20.0%
Q3 2017$91,000
-11.7%
2,272
-4.6%
0.01%0.0%
Q2 2017$103,000
+5050.0%
2,382
+3455.2%
0.01%
Q1 2017$2,000
-95.7%
67
-97.1%
0.00%
-100.0%
Q2 2016$47,000
-88.1%
2,307
-91.1%
0.00%
-89.2%
Q1 2016$394,000
+13.5%
25,8160.0%0.04%
+19.4%
Q4 2015$347,000
-49.7%
25,816
-47.5%
0.03%
-54.4%
Q3 2015$690,00049,1670.07%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders